Palisade Bio, Inc.
PALI
$2.14
-$0.01-0.47%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -279.81% | -330.49% | -166.12% | 17.75% | 31.76% |
| Total Depreciation and Amortization | -- | -- | -- | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5,088.04% | 4,245.45% | 1,540.99% | 3,381.82% | -80.34% |
| Change in Net Operating Assets | -325.53% | 793.60% | 185.02% | -412.57% | 613.39% |
| Cash from Operations | -318.44% | -66.74% | -32.05% | -13.41% | 48.07% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 11.25% | 10.26% | 10.71% | -- |
| Issuance of Common Stock | 4,275.00% | -- | 2,873.43% | -- | -99.90% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 74.16% | -308.33% | -554.41% | 100.00% |
| Cash from Financing | 3,575.00% | 1,314.34% | 3,055.48% | 1,968.33% | -99.89% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -311.25% | 70.78% | 7,097.47% | 94.27% | -2,454.55% |